Tag: <span>Marina Ahmad</span>

North America Legal Chronicle. April 5, 2023

Wellth’s $20 Million Series B Financing Round

By Martina Bellini

Goodwin Procter advised Wellth, Inc. on the deal. Wellth, Inc. announced its $20 million Series B financing round led by SignalFire. Headquartered in Los Angeles, California,...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. January 22, 2022

Eluminex Biosciences’ Acquisition of Zuretinol Acetate Assets from Retinagenix

By Martina Bellini

Goodwin Procter advised Eluminex Biosciences on the deal. Eluminex Biosciences (Suzhou) Limited (Eluminex) announced its acquisition of certain assets and the related global development and commercialization rights...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. December 24, 2021

Qilu Pharmaceutical’s Licensing Agreement and Partnership with Arbutus Biopharma Corporation

By Martina Bellini

Goodwin Procter advised Qilu Pharmaceutical on the deal. Qilu Pharmaceutical, one of the leading pharmaceutical companies in China (“Qilu”), announced its exclusive licensing agreement and strategic partnership...

This content is for Standard 1 Year members only.
Login Join Now

North America. North America Legal Chronicle. June 4, 2021

MorphoSys’ $1.7 Billion Acquisition of Constellation Pharmaceuticals

By Martina Bellini

Wachtell, Lipton, Rosen & Katz and Willkie Farr & Gallagher advised Constellation on the deal. Goodwin Procter, Dechert and Maiwald acted as legal advisors to Royalty...

This content is for Standard 1 Year members only.
Login Join Now

North America. North America Legal Chronicle. May 7, 2021

Amryt Pharma’s Acquisition of Chiasma

By Martina Bellini

Goodwin Procter LLP advised Chiasma, Inc. on the deal. Chiasma, Inc. (Nasdaq: CHMA) announced its definitive agreement to be acquired by Amryt Pharma plc (Nasdaq: AMYT, AIM:...

This content is for Standard 1 Year members only.
Login Join Now

DuploCloud’s $32 Million Series B Funding Round

GATX Corporation’s US$400 Million Senior Notes Offering

Elevai Labs’ $6 Million Initial Public Offering

Sumicity Telecomunicacoes’ R$140 Million Debentures Issuance

Blackrock’s Investment in Brasol

ABG Group’s Acquisition of ABC Technologies

Neosfer’s Spin-Off of Lissi GmbH

Velliv Ejendomme’s Acquisition of an Office Building in Ballerup

S IMMO AG’s Acquisition of a Property Portfolio in the Czech Republic

The Sovereign Fund of Egypt’s Partnership Agreement with Tanweer for Educational Services

Toma Company’s Securing Majority Stake in Dice

Adopen’s Egyptian Market Entry

Tabby’s US$200 Million Series D Financing Round

Linklaters elects two new partners in London and Shanghai

Georg Fischer AG’s Acquisition of a Majority Stake in Corys Piping System

Aster DM Healthcare’s Sale of GCC Business

UltraTech Cement’s Acquisition of Burnpur Cement Limited

ACEN Australia’s Environmental Dispute About Robbins Island Wind Farm

Polsinelli Grows Real Estate Practice in D.C. With Three-Lawyer Team

Cais Advogados celebrates 25 years of achievements with unique style

Gowling WLG accelerates expansion in Germany in line with plan

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Presumption of “Tax Inversion”: The Italian Supreme Court Clarifues That “Mediated” Control Is Not Relevant

Polsinelli Grows Real Estate Practice in D.C. With Three-Lawyer Team

Gowling WLG accelerates expansion in Germany in line with plan

Linklaters elects two new partners in London and Shanghai

Marina Ahmad

Wellth’s $20 Million Series B Financing Round

Eluminex Biosciences’ Acquisition of Zuretinol Acetate Assets from Retinagenix

Qilu Pharmaceutical’s Licensing Agreement and Partnership with Arbutus Biopharma Corporation

MorphoSys’ $1.7 Billion Acquisition of Constellation Pharmaceuticals

Amryt Pharma’s Acquisition of Chiasma